Abstract
Increased ventricular volume enhances the systolic performance, a phenomenon known as Frank-Starlings law of the heart. At its basis is the ability of cardiac muscle to produce increased active force in response to increased muscle length. Although numerous studies have been conducted to elucidate the molecular basis of length-dependent activation, the mechanism remains elusive. The giant protein titin (also known as connectin) is the third filament system in the sarcomere and is responsible for most passive stiffness of striated muscle in the physiological sarcomere length range. The force generated by titin is usually seen as passive and independent of active force generation. Recent findings, however, suggest that titin-based passive force modulates actin-myosin interaction, resulting in greater active force in response to stretch. In this short review, we discuss the molecular mechanisms of length-dependent activation, focusing on the possible role of titin in its regulation.
Keywords: heart, cardiac muscle, frank-starling, sarcomere length, titin
Current Vascular Pharmacology
Title: Role of the Giant Elastic Protein Titin in the Frank-Starling Mechanism of the Heart
Volume: 2 Issue: 2
Author(s): Norio Fukuda and Henk Granzier
Affiliation:
Keywords: heart, cardiac muscle, frank-starling, sarcomere length, titin
Abstract: Increased ventricular volume enhances the systolic performance, a phenomenon known as Frank-Starlings law of the heart. At its basis is the ability of cardiac muscle to produce increased active force in response to increased muscle length. Although numerous studies have been conducted to elucidate the molecular basis of length-dependent activation, the mechanism remains elusive. The giant protein titin (also known as connectin) is the third filament system in the sarcomere and is responsible for most passive stiffness of striated muscle in the physiological sarcomere length range. The force generated by titin is usually seen as passive and independent of active force generation. Recent findings, however, suggest that titin-based passive force modulates actin-myosin interaction, resulting in greater active force in response to stretch. In this short review, we discuss the molecular mechanisms of length-dependent activation, focusing on the possible role of titin in its regulation.
Export Options
About this article
Cite this article as:
Fukuda Norio and Granzier Henk, Role of the Giant Elastic Protein Titin in the Frank-Starling Mechanism of the Heart, Current Vascular Pharmacology 2004; 2 (2) . https://dx.doi.org/10.2174/1570161043476357
DOI https://dx.doi.org/10.2174/1570161043476357 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease.
Current Alzheimer Research Epigenetics: New Concepts of Old Phenomena in Vascular Physiology
Current Vascular Pharmacology RAGE, Diabetes, and the Nervous System
Current Molecular Medicine Progress in the Oral Treatment of Type 2 Diabetes: Update on DPP-IV Inhibitors
Current Diabetes Reviews EDITORIAL (Hot Topic: Renal Sympathetic Denervation and Cardiovascular Disease: Past, Present and Future)
Current Clinical Pharmacology Nitric Oxide Induced Damage and Preventive Effect of Curcumin and Quercetin on Buffalo Brain Cystatin
Current Proteomics Rodent Models of Hemorrhagic Stroke
Current Pharmaceutical Design Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes
Current Alzheimer Research A Review Study on Prakriti (Body Constitution) Specific Herbal Tea in Diabetes Mellitus
Current Traditional Medicine Involvement of PI3K, Akt and RhoA in Oestradiol Regulation of Cardiac iNOS Expression
Current Vascular Pharmacology Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy Leptin Induces Neuroprotection Neurogenesis and Angiogenesis after Stroke
Current Neurovascular Research Diabetic Retinopathy: Current and New Treatment Options
Current Diabetes Reviews Extracellular Vesicles in the Treatment of Parkinson’s Disease: A Review
Current Medicinal Chemistry Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte Interactions
Current Cardiology Reviews Recent Evidence Regarding a Role for Cdk5 Dysregulation in Alzheimers Disease
Current Alzheimer Research Hypertension: Basics Concepts and the Evolving Role of Novel Treatments
Current Hypertension Reviews Thyroid Hormone-Induced Angiogenesis
Current Cardiology Reviews Exploring Old Drugs for the Treatment of Hematological Malignancies
Current Medicinal Chemistry Highly Active Antiretroviral Therapy-Induced Liver Injury
Current Drug Safety